Vivaldi Capital Management LP Amgen Inc Transaction History

Vivaldi Capital Management LP

$340 Million
Q3 2024

A detailed history of Vivaldi Capital Management LP transactions in Amgen Inc stock. As of the latest transaction made, Vivaldi Capital Management LP holds 1,875 shares of AMGN stock, worth $552,243. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,875

Previous 1,827 2.63%

Holding current value

$552,243

Previous $570,000 5.96%

% of portfolio

0.18%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $14,850 - $16,194	48 Added 2.63%	1,875 $604,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $12,612 - $15,326	48 Added 2.7%	1,827 $570,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $48,127 - $58,096	-179 Reduced 9.14%	1,779 $505,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $92,819 - $104,710	363 Added 22.76%	1,958 $563,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1,311 - $1,628	6 Added 0.38%	1,595 $428,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $23,355 - $27,617	109 Added 7.36%	1,589 $352,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $60,285 - $73,478	-267 Reduced 15.28%	1,480 $357,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3,206 - $4,074	14 Added 0.81%	1,747 $458,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $17,058 - $19,239	-76 Reduced 4.2%	1,733 $397,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $115,585 - $128,626	-501 Reduced 21.69%	1,809 $440,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $24,558 - $27,167	-112 Reduced 4.62%	2,310 $562,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $35,400 - $40,512	178 Added 7.93%	2,422 $545,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $99,271 - $110,134	-425 Reduced 15.92%	2,244 $515,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $23,300 - $27,153	-105 Reduced 3.79%	2,669 $671,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $81,142 - $96,626	375 Added 15.63%	2,774 $638,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $12,905 - $14,352	55 Added 2.35%	2,399 $569,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $144,796 - $177,685	732 Added 45.41%	2,344 $567,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $37,723 - $50,031	207 Added 14.73%	1,612 $327,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $45,788 - $58,854	-242 Reduced 14.69%	1,405 $339,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $24,201 - $28,998	-139 Reduced 7.78%	1,647 $319,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $33,506 - $39,277	201 Added 12.68%	1,786 $329,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $50,462 - $56,882	279 Added 21.36%	1,585 $301,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $232,990 - $271,974	1,306 New	1,306 $254,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.

Account

Vivaldi Capital Management LP Amgen Inc Transaction History